12 results on '"Edy Angela Siciliano"'
Search Results
2. Evaluation of Crocin Content and In Vitro Antioxidant and Anti-Glycation Activity of Different Saffron Extracts
- Author
-
Simone Ronsisvalle, Annamaria Panico, Debora Santonocito, Edy Angela Siciliano, Federica Sipala, Lucia Montenegro, and Carmelo Puglia
- Subjects
crocin ,saffron extracts ,antioxidants ,carotenoids ,anti-glycation activity ,Botany ,QK1-989 - Abstract
Crocin, a glycoside carotenoid that exhibits several health benefits, is mainly obtained from saffron (Crocus sativus L.), whose quality and content of phytochemicals can be strongly affected by environmental conditions. Therefore, in this work, the crocin content and in vitro antioxidant activity of saffron extracts obtained from three different varieties (Greek, Sicilian, and Iranian saffron) were assessed. Crocin content in saffron extracts was quantified via ultra-performance liquid chromatography coupled with mass spectrometry. The antioxidant activity of saffron extracts was evaluated using the oxygen radical absorbance capacity (ORAC) assay and nitric oxide (NO) radical scavenging test. The Maillard reaction was used to assess anti-glycation activity. Although the Sicilian and Iranian saffron extracts contained higher amounts of crocin (128 ± 6 ng/mL and 126 ± 4 ng/mL, respectively) compared to the Greek extracts (111 ± 2 ng/mL), ORAC values (50.9 ± 0.5) and % NO inhibition (35.2 ± 0.2) were higher for the Greek variety, which displayed a total phenolic content about two-fold greater than that of the other two extracts. Sicilian and Greek saffron had similar anti-glycation activities, while Iranian saffron was less effective. These results suggest that the antioxidant activity of saffron extracts could be ascribed to their naturally occurring complex mixture of phytochemicals, deserving further investigation as supplements to prevent pathological conditions induced by radical species.
- Published
- 2023
- Full Text
- View/download PDF
3. In Vitro Skin Permeation of Idebenone from Lipid Nanoparticles Containing Chemical Penetration Enhancers
- Author
-
Lucia Montenegro, Ludovica Maria Santagati, Maria Grazia Sarpietro, Francesco Castelli, Annamaria Panico, Edy Angela Siciliano, Francesco Lai, Donatella Valenti, and Chiara Sinico
- Subjects
idebenone ,chemical penetration enhancers ,lipid nanoparticles ,skin permeation ,SLN ,NLC ,Pharmacy and materia medica ,RS1-441 - Abstract
Lipid nanoparticles (LNPs) have been proposed as carriers for drug skin delivery and targeting. As LNPs effectiveness could be increased by the addition of chemical penetration enhancers (PE), in this work, the feasibility of incorporating PE into LNPs to improve idebenone (IDE) targeting to the skin was investigated. LNPs loading IDE 0.7% w/w were prepared using hydrophilic (propylene glycol, PG, 10% w/w or N-methylpyrrolidone, NMP, 10% w/w) and/or lipophilic PE (oleic acid, OA, 1% w/w; isopropyl myristate, IPM, 3.5% w/w; a mixture of 0.5% w/w OA and 2.5% w/w IPM). All LNPs showed small sizes (
- Published
- 2021
- Full Text
- View/download PDF
4. Astaxanthin-Loaded Stealth Lipid Nanoparticles (AST-SSLN) as Potential Carriers for the Treatment of Alzheimer’s Disease: Formulation Development and Optimization
- Author
-
Debora Santonocito, Giuseppina Raciti, Agata Campisi, Giovanni Sposito, Annamaria Panico, Edy Angela Siciliano, Maria Grazia Sarpietro, Elisabetta Damiani, and Carmelo Puglia
- Subjects
astaxanthin ,stealth system ,SLN ,Alzheimer’s disease ,ORAC ,parenteral administration ,Chemistry ,QD1-999 - Abstract
Alzheimer’s disease (AD) is a neurodegenerative disorder associated with marked oxidative stress at the level of the brain. Recent studies indicate that increasing the antioxidant capacity could represent a very promising therapeutic strategy for AD treatment. Astaxanthin (AST), a powerful natural antioxidant, could be a good candidate for AD treatment, although its use in clinical practice is compromised by its high instability. In order to overcome this limit, our attention focused on the development of innovative AST-loaded stealth lipid nanoparticles (AST-SSLNs) able to improve AST bioavailability in the brain. AST-SSLNs prepared by solvent-diffusion technique showed technological parameters suitable for parenteral administration (
- Published
- 2021
- Full Text
- View/download PDF
5. Carob Seeds: Food Waste or Source of Bioactive Compounds?
- Author
-
Debora Santonocito, Giuseppe Granata, Corrada Geraci, Annamaria Panico, Edy Angela Siciliano, Giuseppina Raciti, and Carmelo Puglia
- Subjects
carob fruit ,seed carob ,food waste ,ORAC ,polyphenols ,Pharmacy and materia medica ,RS1-441 - Abstract
(1) Background: For centuries, carob fruit has been used in the food field, while carob seeds have been mainly considered as food waste. Nowadays, there has been considerable attention toward the recovery of the waste plant matrices as possible sources of functional compounds with health properties. Therefore, our goal was to evaluate the health properties of carob seed extracts, and to study the effects of the ripening process on the chemical composition of the extracts. (2) Methods: After the mechanical separation of seeds from carob fruit, an ultrasound-assisted extraction (UAE) was performed to maximize and preserve the quality of bioactive compounds. Seed extracts were characterized by high-performance liquid chromatography (HPLC) and liquid chromatography/mass spectrometry (LC/MS) for the content of bioactive polyphenols, and were finally analyzed by oxygen radical absorbance capacity (ORAC), NO Scavenger (NO) and advanced glyoxidation end products (AGEs) assays, in order to estimate the antioxidant potential of the active compounds. (3) Results: Although both seed extracts of carob unripe (CAR-UR) and ripe (CAR-R) showed an interesting antioxidant activity, CAR-R had greater activity due to the procyanidins content. (4) Conclusions: Based on the obtained results, carob seed extracts could be regarded as interesting source of bioactive antioxidant compounds for a potential application in nutraceutical and food supplement fields.
- Published
- 2020
- Full Text
- View/download PDF
6. Natural Flavones and Flavonols: Relationships among Antioxidant Activity, Glycation, and Metalloproteinase Inhibition
- Author
-
Simone Ronsisvalle, Federica Panarello, Giusy Longhitano, Edy Angela Siciliano, Lucia Montenegro, and Annamaria Panico
- Subjects
antioxidants ,polyphenols ,anti-glycation activity ,metalloproteinases ,Maillard reaction ,Chemistry ,QD1-999 - Abstract
Reactive oxygen and nitrogen species as well as advanced glycation endproducts (AGEs) and metalloproteinases (MMPs) play a key role in the development and progression of degenerative processes of body tissues, including skin. Natural antioxidant flavonoids could be beneficial in inhibiting AGEs’ formation and MMPs’ expression. In this study, the antioxidant activity of flavones (luteolin, apigenin, and chrysin) and flavonols (mirycetin, quercetin, and kaempferol) was compared with their inhibitory effects on both metalloproteinases’ (MMP-1, MMP-2, MMP-9, MMP-13) and AGEs’ formation. Comparisons were performed taking into account the hydroxyl group arrangement and the physico-chemical parameters the binding dissociation enthalpy (BDE), ionization potential (IP), partition coefficient (log P), and topological polar surface area (TPSA). Increasing the number of hydroxyl groups led to a proportional enhancement of antioxidant activity while an inverse relationship was observed plotting the antioxidant activity vs. BDE and IP values. All flavonoids acted as AGEs, MMP-1, and MMP-13 inhibitors, but they were less effective against MMP-2 and MMP-9. The inhibition of MMP-1 seemed to be related to the TPSA values while high TPSA and low log P values seemed important conditions for inhibiting MMP-13. Overall, our data suggest that an estimation of flavonoid activity could be anticipated based on their physico-chemical parameters.
- Published
- 2020
- Full Text
- View/download PDF
7. Curcumin Containing PEGylated Solid Lipid Nanoparticles for Systemic Administration: A Preliminary Study
- Author
-
Debora Santonocito, Maria Grazia Sarpietro, Claudia Carbone, Annamaria Panico, Agata Campisi, Edy Angela Siciliano, Giovanni Sposito, Francesco Castelli, and Carmelo Puglia
- Subjects
curcumin ,PEGylation ,stealth system ,SLN ,Turbiscan ,TEM ,Organic chemistry ,QD241-441 - Abstract
Curcumin (CUR) has a wide range of pharmacological properties, including anti-inflammatory and antioxidant activities, and it can be considered a good candidate for the potential treatment of central nervous system (CNS) pathologies, although its use in clinical practice is compromised due to its high lipophilicity. Solid lipid nanoparticles (SLNs) are well-known nanocarriers representing a consolidated approach for the delivery of lipophilic compounds, but their systemic use is limited due their short half-life. The formulation of stealth SLNs (pSLNs) could be a valid strategy to overcome this limit. Curcumin-loaded-pSLNs were prepared by the solvent evaporation method. Formulation was characterized for their mean size, zeta potential, size distribution, and morphology. Drug antioxidant activity was evaluated by Oxygen Radical Absorbance Capacity (ORAC) assay. Finally, the obtained formulations were analyzed in terms of long-term stability. Curcumin-loaded-pSLNs showed good technological parameters with a mean particle size below 200 nm, as confirmed by TEM images, and a zeta potential value around −30 mV, predicting good long-term stability. Differential Scanning Calorimetry (DSC) analysis confirmed that PEG micelles interacted with the SLN surface; this suggests the location of the PEG on the pSLN surface. Therefore, these preliminary studies suggest that the produced formulation could be regarded as a promising carrier for the systemic administration.
- Published
- 2020
- Full Text
- View/download PDF
8. Solid Lipid Nanoparticles Loading Idebenone Ester with Pyroglutamic Acid: In Vitro Antioxidant Activity and In Vivo Topical Efficacy
- Author
-
Lucia Montenegro, Anna Maria Panico, Ludovica Maria Santagati, Edy Angela Siciliano, Sebastiano Intagliata, and Maria N. Modica
- Subjects
idebenone ,solid lipid nanoparticles ,nanocarriers ,pyroglutamic acid ,idebenone derivative ,antioxidant activity ,ORAC assay ,anti-glycation activity ,skin hydration ,Chemistry ,QD1-999 - Abstract
Idebenone (IDE), a strong antioxidant widely investigated for the treatment of neurodegenerative diseases and skin disorders, shows low oral and topical bioavailability due to its unfavorable physico-chemical properties. In this work, to improve IDE topical effectiveness, we explored a two-steps approach: (1) we synthesized an IDE ester (IDEPCA) with pyroglutamic acid, a molecule whose hydrating effects are well known; (2) we loaded IDEPCA into solid lipid nanocarriers (SLN). We evaluated in vitro antioxidant and anti-glycation activity and in vivo hydrating effects after topical application in human volunteers from gel vehicles of IDEPCA SLN in comparison to IDE SLN. All SLN showed good technological properties (mean particle size < 25 nm, polydispersity index < 0.300, good stability). The oxygen radical absorbance capacity assay showed that IDEPCA SLN and IDE SLN had similar antioxidant activity while IDEPCA SLN were more effective in the in vitro NO scavenging assay. Both IDEPCA and IDE SLN showed the same effectiveness in inhibiting the formation of advanced glycation end products. In vivo experiments pointed out a better hydrating effect of IDEPCA SLN in comparison to IDE SLN. These results suggest that the investigated approach could be a promising strategy to obtain topical formulations with increased hydrating effects.
- Published
- 2018
- Full Text
- View/download PDF
9. In Vitro Skin Permeation of Idebenone from Lipid Nanoparticles Containing Chemical Penetration Enhancers
- Author
-
Francesco Castelli, Annamaria Panico, Lucia Montenegro, Donatella Valenti, Chiara Sinico, Francesco Lai, Maria Grazia Sarpietro, Edy Angela Siciliano, and Ludovica Maria Santagati
- Subjects
Antioxidant ,Oxygen radical absorbance capacity ,medicine.medical_treatment ,Dispersity ,Pharmaceutical Science ,skin permeation ,SLN ,02 engineering and technology ,lipid nanoparticles ,030226 pharmacology & pharmacy ,Polyvinyl alcohol ,Article ,03 medical and health sciences ,chemistry.chemical_compound ,Pharmacy and materia medica ,0302 clinical medicine ,idebenone ,chemical penetration enhancers ,NLC ,medicine ,Isopropyl myristate ,Penetration (firestop) ,Permeation ,021001 nanoscience & nanotechnology ,RS1-441 ,Oleic acid ,chemistry ,0210 nano-technology ,Nuclear chemistry - Abstract
Lipid nanoparticles (LNPs) have been proposed as carriers for drug skin delivery and targeting. As LNPs effectiveness could be increased by the addition of chemical penetration enhancers (PE), in this work, the feasibility of incorporating PE into LNPs to improve idebenone (IDE) targeting to the skin was investigated. LNPs loading IDE 0.7% w/w were prepared using hydrophilic (propylene glycol, PG, 10% w/w or N-methylpyrrolidone, NMP, 10% w/w) and/or lipophilic PE (oleic acid, OA, 1% w/w, isopropyl myristate, IPM, 3.5% w/w, a mixture of 0.5% w/w OA and 2.5% w/w IPM). All LNPs showed small sizes (<, 60 nm), low polydispersity index and good stability. According to the obtained results, IDE release from LNPs was not the rate-limiting step in IDE skin penetration. No IDE permeation was observed through excised pigskin from all LNPs, while the greatest increase of IDE penetration into the different skin layers was obtained using the mixture OA/IPM. The antioxidant activity of IDE-loaded LNPs, determined by the oxygen radical absorbance capacity assay, was greater than that of free IDE. These results suggest that the use of suitable PE as LNPs components could be regarded as a promising strategy to improve drug targeting to the skin.
- Published
- 2021
10. Astaxanthin-Loaded Stealth Lipid Nanoparticles (AST-SSLN) as Potential Carriers for the Treatment of Alzheimer's Disease: Formulation Development and Optimization
- Author
-
Giuseppina Raciti, Carmelo Puglia, Maria Grazia Sarpietro, Agata Campisi, Giovanni Sposito, Elisabetta Damiani, Edy Angela Siciliano, Annamaria Panico, and Debora Santonocito
- Subjects
Antioxidant ,Oxygen radical absorbance capacity ,General Chemical Engineering ,medicine.medical_treatment ,SLN ,02 engineering and technology ,Pharmacology ,medicine.disease_cause ,digestive system ,Article ,lcsh:Chemistry ,03 medical and health sciences ,chemistry.chemical_compound ,Astaxanthin ,medicine ,General Materials Science ,MTT assay ,stealth system ,030304 developmental biology ,0303 health sciences ,Chemistry ,021001 nanoscience & nanotechnology ,parenteral administration ,digestive system diseases ,Bioavailability ,astaxanthin ,lcsh:QD1-999 ,Systemic administration ,ORAC ,Nanocarriers ,0210 nano-technology ,Alzheimer’s disease ,Oxidative stress - Abstract
Alzheimer’s disease (AD) is a neurodegenerative disorder associated with marked oxidative stress at the level of the brain. Recent studies indicate that increasing the antioxidant capacity could represent a very promising therapeutic strategy for AD treatment. Astaxanthin (AST), a powerful natural antioxidant, could be a good candidate for AD treatment, although its use in clinical practice is compromised by its high instability. In order to overcome this limit, our attention focused on the development of innovative AST-loaded stealth lipid nanoparticles (AST-SSLNs) able to improve AST bioavailability in the brain. AST-SSLNs prepared by solvent-diffusion technique showed technological parameters suitable for parenteral administration (<, 200 nm). Formulated nanosystems were characterized by calorimetric studies, while their toxicological profile was evaluated by the MTT assay on the stem cell line OECs (Olfactory Ensheathing Cells). Furthemore, the protective effect of the nanocarriers was assessed by a long-term stability study and a UV stability assay confirming that the lipid shell of the nanocarriers was able to preserve AST concentration in the formulation. SSLNs were also capable of preserving AST’s antioxidant capacity as demonstrated in the oxygen radical absorbance capacity (ORAC) assay. In conclusion, these preliminary studies outline that SSLNs could be regarded as promising carriers for systemic administration of compounds such as AST aimed at AD treatment.
- Published
- 2021
11. In Vitro Antioxidant and Anti-Glycation Activity of Resveratrol and Its Novel Triester with Trolox
- Author
-
Lucia Montenegro, Maria N. Modica, Sabrina Barbagallo, Edy Angela Siciliano, Sebastiano Intagliata, Miriam Lorenti, Annamaria Panico, Benito Macaluso, Shyam H. Kamble, and Angelo Spadaro
- Subjects
0301 basic medicine ,Antioxidant ,antioxidant ,Oxygen radical absorbance capacity ,Physiology ,medicine.medical_treatment ,Clinical Biochemistry ,trolox ,Resveratrol ,resveratrol ,Biochemistry ,Article ,Polar surface area ,chemical stability ,03 medical and health sciences ,symbols.namesake ,chemistry.chemical_compound ,0302 clinical medicine ,Glycation ,medicine ,Molecular Biology ,Chemistry ,Vitamin E ,lcsh:RM1-950 ,Cell Biology ,Maillard reaction ,lcsh:Therapeutics. Pharmacology ,030104 developmental biology ,resveratrol derivative ,030220 oncology & carcinogenesis ,symbols ,anti-glycation ,Trolox - Abstract
Resveratrol (RSV) is well known for its many beneficial activities, but its unfavorable physicochemical properties impair its effectiveness after systemic and topical administration, thus, several strategies have been investigated to improve RSV efficacy. With this aim, in this work, we synthesized a novel RSV triester with trolox, an analogue of vitamin E with strong antioxidant activity. The new RSV derivative (RSVTR) was assayed in vitro to evaluate its antioxidant and anti-glycation activity compared to RSV. RSVTR chemical stability was assessed at pH 2.0, 6.8, and 7.2 and different storage temperatures (5 °, C, 22 °, C, and 37 °, C). An influence of pH stronger than that of temperature on RSVTR half-life values was pointed out, and RSVTR greatest stability was observed at pH 7.2 and 5 °, C. RSVTR showed a lower antioxidant ability compared to RSV (determined by the oxygen radical absorbance capacity assay) while its anti-glycation activity (evaluated using the Maillard reaction) was significantly greater than that of RSV. The improved ability to inhibit the glycation process was attributed to a better interaction of RSVTR with albumin owing to its increased topological polar surface area value and H-bond acceptor number compared to RSV. Therefore, RSVTR could be regarded as a promising anti-glycation agent worthy of further investigations.
- Published
- 2020
- Full Text
- View/download PDF
12. Solid Lipid Nanoparticles Loading Idebenone Ester with Pyroglutamic Acid: In Vitro Antioxidant Activity and In Vivo Topical Efficacy
- Author
-
Edy Angela Siciliano, Ludovica Maria Santagati, Maria N. Modica, Anna Maria Panico, Lucia Montenegro, and Sebastiano Intagliata
- Subjects
0301 basic medicine ,Anti-glycation activity ,Antioxidant activity ,Idebenone ,Idebenone derivative ,Nanocarriers ,ORAC assay ,Pyroglutamic acid ,Skin hydration ,Solid lipid nanoparticles ,Chemical Engineering (all) ,Materials Science (all) ,pyroglutamic acid ,Antioxidant ,Oxygen radical absorbance capacity ,General Chemical Engineering ,medicine.medical_treatment ,antioxidant activity ,02 engineering and technology ,Pharmacology ,Article ,idebenone derivative ,lcsh:Chemistry ,03 medical and health sciences ,chemistry.chemical_compound ,Glycation ,In vivo ,Solid lipid nanoparticle ,medicine ,General Materials Science ,skin hydration ,nanocarriers ,anti-glycation activity ,Chemistry ,021001 nanoscience & nanotechnology ,idebenone ,solid lipid nanoparticles ,030104 developmental biology ,lcsh:QD1-999 ,0210 nano-technology ,medicine.drug - Abstract
Idebenone (IDE), a strong antioxidant widely investigated for the treatment of neurodegenerative diseases and skin disorders, shows low oral and topical bioavailability due to its unfavorable physico-chemical properties. In this work, to improve IDE topical effectiveness, we explored a two-steps approach: (1) we synthesized an IDE ester (IDEPCA) with pyroglutamic acid, a molecule whose hydrating effects are well known, (2) we loaded IDEPCA into solid lipid nanocarriers (SLN). We evaluated in vitro antioxidant and anti-glycation activity and in vivo hydrating effects after topical application in human volunteers from gel vehicles of IDEPCA SLN in comparison to IDE SLN. All SLN showed good technological properties (mean particle size <, 25 nm, polydispersity index <, 0.300, good stability). The oxygen radical absorbance capacity assay showed that IDEPCA SLN and IDE SLN had similar antioxidant activity while IDEPCA SLN were more effective in the in vitro NO scavenging assay. Both IDEPCA and IDE SLN showed the same effectiveness in inhibiting the formation of advanced glycation end products. In vivo experiments pointed out a better hydrating effect of IDEPCA SLN in comparison to IDE SLN. These results suggest that the investigated approach could be a promising strategy to obtain topical formulations with increased hydrating effects.
- Published
- 2018
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.